메뉴 건너뛰기




Volumn 21, Issue 3, 2012, Pages 327-329

Targeting Tumor Architecture to Favor Drug Penetration: A New Weapon to Combat Chemoresistance in Pancreatic Cancer?

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ERISMODEGIB; GEMCITABINE; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; PEGPH 20; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; VISMODEGIB;

EID: 84858594444     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.03.002     Document Type: Short Survey
Times cited : (70)

References (10)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.